002466:SZSETianqi Lithium Corporation Analysis
Data as of 2026-05-21 - not real-time
CN¥67.29
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Tianqi Lithium is trading at CNY 67.29, just above the computed support of CNY 65.26 but well below its 20‑day SMA of CNY 72.97, indicating short‑term price pressure. The MACD shows a bearish divergence (histogram ‑1.69) and the RSI sits at 46, suggesting limited upside momentum in the near term. Revenue has nearly doubled year‑over‑year (≈98% growth) and the company enjoys an extraordinary operating margin of 59%, underscoring strong profitability in the lithium segment. However, the current PE of ~51× earnings and a forward PE of ~21× imply the stock is priced for premium growth, especially when the DCF‑derived fair value is only a fraction of the market price. The balance sheet is leveraged, with a debt‑to‑equity ratio above 25, though ample cash holdings (≈CNY 10 bn) provide a cushion. Volatility is high at 56% over the past 30 days, but beta is exceptionally low (~0.09), indicating limited systematic market risk. The broader market sentiment is in “Extreme Greed” (fear‑greed index 90), which may be inflating valuations across the sector. With no dividend payout, investors must rely on capital appreciation driven by lithium demand. Looking ahead, the 12‑month upside potential is modest at around 10%, while downside risk remains tied to commodity price swings and regulatory scrutiny in mining jurisdictions.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support with bearish MACD
- Decreasing volume trend
- High valuation relative to earnings
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust revenue growth and operating margins
- Secular demand for lithium in EV batteries
- Improving forward PE and earnings outlook
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term lithium supply‑demand fundamentals
- Geographic diversification across Australia, Chile, and China
- Strong cash position to fund expansion
Key Metrics & Analysis
Financial Health
Revenue Growth98.40%
Profit Margin17.33%
P/E Ratio51.0
ROE9.52%
ROA4.25%
Debt/Equity25.54
P/B Ratio2.4
Op. Cash FlowCN¥2.3B
Free Cash FlowCN¥263.5M
Technical Analysis
TrendBullish
RSI46.4
SupportCN¥65.26
ResistanceCN¥82.49
MA 20CN¥72.97
MA 50CN¥63.00
MA 200CN¥53.56
MACDBearish
VolumeDecreasing
Fear & Greed Index90.29
Valuation
Fair ValueCN¥2.73
Target PriceCN¥73.87
Upside/Downside9.78%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.09
Volatility56.20%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.